 who are candidates for endovenous therapy and wish to proceed. Evidence for efﬁcacy of compression therapy in these patients
is less than for efﬁcacy of endovenous ablation (Table IV).
Evidence. Insurance companies and the Centers for
Medicare and Medicaid Services frequently require a 3month trial of compression stockings before intervention
for patients with C2 disease, despite a lack of evidence for
efﬁcacy.90 In a UK-based cost analysis,9